SCHEMBL25718166

SCHEMBL25718166

CCC1(CC)c2cc(C(F)(F)F)ccc2-c2c1c1c(c3cc(OC)ccc23)OC(c2ccc(N3CCOCC3)cc2)(c2ccc(N3CCOCC3)cc2)C=C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 3/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
RAF1 P04049 1/20 0.32
CACNA1G O43497 1/20 0.32
KCNH2 Q12809 1/20 0.32
CSF1R P07333 2/20 0.31
LCK P06239 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
RAB9A P51151 1/20 0.31
EGFR P00533 1/20 0.31
CDK2 P24941 1/20 0.31
PRKDC P78527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25607034 0.99 ADAM17 (0.33) ADAM17SMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL25718163 0.97 HTR1A (0.33) ADAM17SMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL25600425 0.93 ADAM17 (0.36) ADAM17SMN1; SMN2L3MBTL1MAPTPOLB
SCHEMBL25600424 0.93 RAB9A (0.36) ADAM17SMN1; SMN2L3MBTL1MAPTPOLB
SCHEMBL26629559 0.92 MEN1 (0.34) KMT2ACACNA1GKCNH2CSF1RLCK
SCHEMBL25844717 0.90 ADAM17 (0.34) ADAM17SMN1; SMN2L3MBTL1MAPTPOLB
SCHEMBL25718161 0.90 LMNA (0.34) ADAM17SMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL25607032 0.90 CCNB2 (0.31) LMNAPOLBTSHRKMT2AHSD17B10
SCHEMBL25607024 0.90 LMNA (0.33) ADAM17SMN1; SMN2L3MBTL1LMNAMAPT
SCHEMBL25844714 0.90 RAB9A (0.34) ADAM17SMN1; SMN2L3MBTL1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269532-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed
EP-4198583-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES Hoya Lens Thailand Ltd. (TH) 2023-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 ADAM17 4791/4885SMN1; SMN2 3937/4885L3MBTL1 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.